Alan Klitenic, Director of Investor Relations for, Discusses Recent CIIX News and Industry Trends in a New Audio Interview with

AUSTIN, Texas, Sept. 20, 2017 (GLOBE NEWSWIRE) —, Inc. and (OTCQB:CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, and a well-known cannabidiol (CBD) health brand engaged in the development, manufacturing, marketing and distribution of consumer products containing CBD, today announce that the Company’s director of investor relations, Alan Klitenic, is featured in an audio interview at

The interview outlining CIIX’s current news and efforts can be heard at

Alan Klitenic, director of investor relations for called in to, Inc. to discuss the recent news for the company. Topics covered in the interview include the recent news in the Digital Currency Industry, the plans that the Company has regarding launching a Chinese Daily Video News Broadcast from the NYSE floor covering the Digital Currency Market, exciting news about its recent financial performance, and insights on all recent news including the recently announced completion of the record filing process with the Chinese FDA the soon to be launched Hemp Infused Skin Care Line in China starting in October.

During the interview Klitenic stated, “I want to emphatically state that CIIX is ready to make sales in China. We have successfully passed thru the regulatory body, the China FDA. We have manufactured this product: CBD Infused skin care products line with a design patent. This is a real milestone for us at We are going to spend money and promote our CBD Hemp Oil and CBD infused skin care products in China going forward from now and thru 2018."

About is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks in which they are interested. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and its services, please visit


Founded in 1999, endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online sales and direct sales of non-industrial hemp-based products and other health related products.

For more information visit

Subscribe and watch our video commentaries:

Follow us on Twitter for real-time Company updates:

Like us on Facebook to receive live feeds:;

Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Contact:, Inc.
227 W. Valley Blvd, #208 A
San Gabriel, CA 91776

Investor Relations:

Alan Klitenic

Corporate Communications:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office
[email protected]


Stuart T. Smith
[email protected]